University of Vermont

About: University of Vermont is a education organization based out in Burlington, Vermont, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 17592 authors who have published 38251 publications receiving 1609874 citations. The organization is also known as: UVM & University of Vermont and State Agricultural College.

The Impact of Obesity on the Left Ventricle: The Multi-Ethnic Study of Atherosclerosis (MESA)

Abstract: Objectives The purpose of this study was to evaluate the relationship of left ventricular (LV) remodeling assessed by cardiac magnetic resonance to various measures of obesity in a large population-based study. Background Obesity is a well-known risk factor for cardiovascular disease, yet its relationship with LV size and function is poorly understood. Methods A total of 5,098 participants (age 45 to 84 years; 48% men) in the Multi-Ethnic Study of Atherosclerosis who were free of clinically apparent cardiovascular disease underwent cardiac magnetic resonance to assess LV size and function as well as measures of obesity, including body mass index, waist-to-hip ratio and waist circumference, and cardiovascular risk factors. Fat mass (FM) was estimated based on height-weight models derived from bioelectrical impedance studies. The associations of obesity measures with LV size and function were evaluated using linear spline regression models for body mass index and multivariable regression models for other measures of obesity; they were displayed graphically using generalized additive models. Results LV mass and end-diastolic volume were positively associated with measures of obesity in both sexes after adjustment for risk factors (e.g., 5.7-g and 6.9-g increase in LV mass per 10-kg increase in FM in women and men, respectively [p Conclusions Obesity was associated with concentric LV remodeling without change in ejection fraction in a large, multiethnic cohort study.

Prevalence of Mammographically Dense Breasts in the United States

Abstract: Background National legislation is under consideration that would require women with mammographically dense breasts to be informed of their breast density and encouraged to discuss supplemental breast cancer screening with their health care providers. The number of US women potentially affected by this legislation is unknown.

Endurance training does not enhance total energy expenditure in healthy elderly persons

Abstract: Physical exercise is prescribed to older individuals to increase cardiovascular fitness and improve body composition. However, there is limited information on the effect of exercise on total energy expenditure (TEE) and its components. We therefore determined the effects of short-term endurance training in 11 elderly volunteers (56-78 years) on changes in 1) TEE, from doubly labeled water; 2) resting metabolic rate (RMR), from respiratory gas analysis, 3) the energy expenditure of physical activity (EEPA), aside from that associated with the training program, and 4) body composition from a combination of body density with total body water. Endurance training increased maximum oxygen consumption (VO2max) by 9% (2.00 +/- 0.67 to 2.17 +/- 0.64 l/min; P < 0.05) and RMR by 11% (1,596 +/- 214 to 1,763 +/- 170 kcal/day; P < 0.01). There was no significant change in TEE (2,408 +/- 478 to 2,479 +/- 497 kcal/day) before and during the last 10 days of endurance training because of a 62% reduction in EEPA (571 +/- 386 to 340 +/- 452 kcal/day; P < 0.01). There was no change in body mass, but fat mass decreased (21.6 +/- 6.6 to 20.7 +/- 6.6 kg; P < 0.05). The increase in fat-free mass (49.5 +/- 9.0 to 50.4 +/- 9.1 kg; P < 0.05) was explained by an increase in body water (35.9 +/- 6.5 to 36.8 +/- 6.3 kg; P < 0.05). We conclude that in healthy elderly persons, endurance training enhances cardiovascular fitness, but does not increase TEE because of a compensatory decline in physical activity during the remainder of the day.

Crop Domestication and Its Impact on Naturally Selected Trophic Interactions

Abstract: Crop domestication is the process of artificially selecting plants to increase their suitability to human requirements: taste, yield, storage, and cultivation practices. There is increasing evidence that crop domestication can profoundly alter interactions among plants, herbivores, and their natural enemies. Overall, little is known about how these interactions are affected by domestication in the geographical ranges where these crops originate, where they are sympatric with the ancestral plant and share the associated arthropod community. In general, domestication consistently has reduced chemical resistance against herbivorous insects, improving herbivore and natural enemy performance on crop plants. More studies are needed to understand how changes in morphology and resistance-related traits arising from domestication may interact with environmental variation to affect species interactions across multiple scales in agroecosystems and natural ecosystems.

Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial

Abstract: Summary Background Local excision is an organ-preserving treatment alternative to transabdominal resection for patients with stage I rectal cancer. However, local excision alone is associated with a high risk of local recurrence and inferior survival compared with transabdominal rectal resection. We investigated the oncological and functional outcomes of neoadjuvant chemoradiotherapy and local excision for patients with stage T2N0 rectal cancer. Methods We did a multi-institutional, single-arm, open-label, non-randomised, phase 2 trial of patients with clinically staged T2N0 distal rectal cancer treated with neoadjuvant chemoradiotherapy at 26 American College of Surgeons Oncology Group institutions. Patients with clinical T2N0 rectal adenocarcinoma staged by endorectal ultrasound or endorectal coil MRI, measuring less than 4 cm in greatest diameter, involving less than 40% of the circumference of the rectum, located within 8 cm of the anal verge, and with an Eastern Cooperative Oncology Group performance status of at least 2 were included in the study. Neoadjuvant chemoradiotherapy consisted of capecitabine (original dose 825 mg/m 2 twice daily on days 1–14 and 22–35), oxaliplatin (50 mg/m 2 on weeks 1, 2, 4, and 5), and radiation (5 days a week at 1·8 Gy per day for 5 weeks to a dose of 45 Gy, followed by a boost of 9 Gy, for a total dose of 54 Gy) followed by local excision. Because of adverse events during chemoradiotherapy, the dose of capecitabine was reduced to 725 mg/m 2 twice-daily, 5 days per week, for 5 weeks, and the boost of radiation was reduced to 5·4 Gy, for a total dose of 50·4 Gy. The primary endpoint was 3-year disease-free survival for all eligible patients (intention-to-treat population) and for patients who completed chemotherapy and radiation, and had ypT0, ypT1, or ypT2 tumours, and negative resection margins (per-protocol group). This study is registered with ClinicalTrials.gov, number NCT00114231. Findings Between May 25, 2006, and Oct 22, 2009, 79 eligible patients were recruited to the trial and started neoadjuvant chemoradiotherapy. Two patients had no surgery and one had a total mesorectal excision. Four additional patients completed protocol treatment, but one had a positive margin and three had ypT3 tumours. Thus, the per-protocol population consisted of 72 patients. Median follow-up was 56 months (IQR 46–63) for all patients. The estimated 3-year disease-free survival for the intention-to-treat group was 88·2% (95% CI 81·3–95·8), and for the per-protocol group was 86·9% (79·3–95·3). Of 79 eligible patients, 23 (29%) had grade 3 gastrointestinal adverse events, 12 (15%) had grade 3–4 pain, and 12 (15%) had grade 3–4 haematological adverse events during chemoradiation. Of the 77 patients who had surgery, six (8%) had grade 3 pain, three (4%) had grade 3–4 haemorrhage, and three (4%) had gastrointestinal adverse events. Interpretation Although the observed 3-year disease free survival was not as high as anticipated, our data suggest that neoadjuvant chemoradiotherapy followed by local excision might be considered as an organ-preserving alternative in carefully selected patients with clinically staged T2N0 tumours who refuse, or are not candidates for, transabdominal resection. Funding National Cancer Institute and Sanofi-Aventis.